Leukemia
1,664
99
141
1,058
Key Insights
Highlights
Success Rate
83% trial completion
Published Results
379 trials with published results (23%)
Research Maturity
1058 completed trials (64% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
13.0%
217 terminated out of 1664 trials
83.0%
-3.6% vs benchmark
9%
154 trials in Phase 3/4
36%
379 of 1058 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1058 completed trials
Clinical Trials (1664)
Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers
Dyadic Physical Activity Intervention for Children Undergoing Cancer Treatment
Efficacy of Seated Exercise on Functional Capacity and Quality of Life in Patients With Leukemia During Chemotherapy Cycles
Natural History Study of Early Life Exposures in Agriculture (ELEA)
A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous Cladribine
05-001: Treatment of Acute Lymphoblastic Leukemia in Children
Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia
Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant
CIML NK Cells With Venetoclax for AML
Weight Gain in Pediatric Leukemia Survivors
Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Mindfulness Interventions to Improve Health Activation, Coping, and Stress Among Childhood Cancer Survivors
Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases
A Phase II Study of Ibrutinib Plus FCR in Previously Untreated, Younger Patients With Chronic Lymphocytic Leukemia
Rutgers University Study of the Genetics of Blood Cancers
Case-Control Study of Pesticides and Childhood Leukemia
Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
Pilot of a Trial Enrollment Diversity Dashboard
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)